- 1、本文档共10页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
孟鲁司特纳治疗小儿持续性哮喘疗效评估与研究
孟鲁司特纳治疗小儿持续性哮喘疗效评估与研究
[摘要] 目的 评估与研究孟鲁司特钠治疗小儿持续性哮喘的临床治疗效果。方法 方便选择2013年1月―2015年12月该院收治的64例持续性哮喘患儿作为研究对象,根据随机数字法将64例哮喘患儿均分成对照组与观察组,其中对照组仅应用布地奈德治疗,而观察组在对照组用药基础上联合孟鲁司特钠治疗,对比两组哮喘患儿的治疗效果。结果 观察组痊愈25例,有效6例,无效1例,总有效率为96.88%;对照组痊愈18例,有效6例,无效8例,总有效率为75.00%;对比观察组与对照组治疗总有效率,观察组治疗效果更为理想,两组对比差异有统计学意义(P0.05);治疗后6个月随访,观察组哮喘复发1例,哮喘复发率达3.13%,对照组哮喘复发6例,哮喘复发率达18.75%,对比两组患儿复发率,观察组复发率明显比对照组低,两组对比差异有统计学意义(P0.05)。结论 孟鲁司特钠治疗小儿持续性哮喘疗效理想,能明显提高临床治疗效果,降低哮喘复发率,值得推广应用。
[关键词] 孟鲁司特钠;持续性哮喘;治疗效果;复发
[中图分类号] R562 [文献标识码] A [文章编号] 1674-0742(2017)01(b)-0022-03
[Abstract] Objective To evaluate and research the curative effect of montelukast in treatment of persistent asthma in children. Methods Convenient selection 64 cases of children with persistent asthma admitted and treated in our hospital from January 2013 to December 2015 were selected as the research objects and randomly divided into two groups, the control group only adopted the budesonide, while the observation group adopted the montelukast on the basis of the control group, and the treatment effect of the two groups was compared. Results 25 cases were cured, 6 cases were effective, 1 case was ineffective, and the total effective rate was 96.88% in the observation group, and 18 cases were cured, 6 cases were effective, 8 cases were ineffective, and the total effective rate was 75.00% in the control group, and the treatment effect in the observation group was more ideal than that in the control group, and the difference between the two groups had statistical significance(P0.05), after 6-month treatment, the follow-up showed that the recurrence of asthma was in 1 case, and the recurrence rate of asthma reached 3.13% in the observation group, and the recurrence of asthma was in 6 cases, and the recurrence rate of asthma reached 18.75%, and the recurrence rate in the observation group was lower than that in the control group, and the difference had statistical significance(P0.05). Conclusion The curative effect of montelukast in treatment
您可能关注的文档
最近下载
- 市场营销原理(第13版) 科特勒 课件 中文版.ppt
- 陕西省全省性社会团体章程示范文本(陕西省2022版).pdf VIP
- 2025学年高一下学期期中考试物理试卷 Word版含答案 .pdf VIP
- 2023高考语文新课标I卷现代文阅读II《给儿子》小说精读及试题详解.docx
- 2025年许昌电气职业学院单招职业适应性测试题库往年题考.docx VIP
- 寿盒(骨灰盒)供应及售后服务方案.pdf VIP
- 适老化全场景技术规范 第2部分:既有居住建筑适老化改造技术标准 .pdf VIP
- 生态系统多样性及保护.pptx VIP
- (高清版)ZT 0331-2020 地热资源评价方法及估算规程.pdf VIP
- T∕CBMCA 057.1-2024 适老化全场景技术规范 第1部分:居住建筑适老化基本要求.pdf
文档评论(0)